Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market
Posted
August 7, 2024
Views
3,184
Likes
44
Comments
3
Engagement
August 7, 2024
3,184
44
3
1.48%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
9:39Now PlayingNovo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen discusses Wegovy and Ozempic sales, the US market and the scaling of manufacturing. He speaks to Francine Lacqua on Bloomberg Television.
Sign up for the 5 Things to Start Your Day newsletter to get up to speed with the most important business & markets news each morning
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
